Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | +2.60% | -4.24% | +3.27% |
Apr. 22 | Transcript : Lexicon Pharmaceuticals, Inc. - Analyst/Investor Day | |
Mar. 25 | Lexicon Pharmaceuticals Files Prospectus for Secondary Offering | MT |
Evolution of the average Target Price on Lexicon Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Lexicon Pharmaceuticals, Inc.
Citigroup | |
Jefferies & Co. | |
Piper Sandler | |
Wedbush | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- LXRX Stock
- Consensus Lexicon Pharmaceuticals, Inc.